mubritinib

Ligand id: 6011

Name: mubritinib

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 4
Hydrogen bond donors 0
Rotatable bonds 11
Topological polar surface area 65.97
Molecular weight 468.18
XLogP 7.75
No. Lipinski's rules broken 2

Molecular properties generated using the CDK

Classification
Compound class Synthetic organic
IUPAC Name
1-[4-[4-[[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methoxy]phenyl]butyl]triazole
International Nonproprietary Names
INN number INN
8446 mubritinib
Synonyms
TAK 165 | TAK-165 | TAK165
Database Links
CAS Registry No. 366017-09-6
ChEMBL Ligand CHEMBL1614707
PubChem CID 6444692
Search Google for chemical match using the InChIKey ZTFBIUXIQYRUNT-MDWZMJQESA-N
Search Google for chemicals with the same backbone ZTFBIUXIQYRUNT
Search PubMed clinical trials mubritinib
Search PubMed titles mubritinib
Search PubMed titles/abstracts mubritinib
Search UniChem for chemical match using the InChIKey ZTFBIUXIQYRUNT-MDWZMJQESA-N
Search UniChem for chemicals with the same backbone ZTFBIUXIQYRUNT
Wikipedia Mubritinib
Comments
Mubritinib is a reversible inhibitor of EGFR and HER2. This compound is a Phase I clinical candidate.